FERRIC FERROCYANIDE

First marketed in 1921

Details

Stereochemistry	ACHIRAL
Molecular Formula	18CN.7Fe
Molecular Weight	859.228
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

[Fe++].[Fe++].[Fe++].[Fe+3].[Fe+3].[Fe+3].[Fe+3].[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N

InChI

InChIKey=DCYOBGZUOMKFPA-UHFFFAOYSA-N

InChI=1S/18CN.7Fe/c18*1-2;;;;;;;/q18*-1;3*+2;4*+3

HIDE SMILES / InChI

Molecular Formula	Fe
Molecular Weight	55.845
Charge	3
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Molecular Formula	CHN
Molecular Weight	27.0253
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Molecular Formula	Fe
Molecular Weight	55.845
Charge	2
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: http://www.drugfuture.com/chemdata/ferroglycine-sulfate.htmlhttp://nj.gov/health/eoh/rtkweb/documents/fs/0928.pdfhttps://www.drugs.com/inactive/ferrous-oxide-389.htmlhttp://www.druglead.com/cds/ferrous-iodide.htmlhttps://www.ncbi.nlm.nih.gov/pubmed/16694502http://www.foodchemadditives.com/products/Ferrous-Lactatehttps://www.ncbi.nlm.nih.gov/pubmed/14116934DOI: 10.1021/ja00949a016 Retrived from http://pubs.acs.org/doi/abs/10.1021/ja00949a016
Curator's Comment: description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/3541174 | https://books.google.ru/books?id=7mxyBgAAQBAJ&pg=PA13&lpg=PA13&dq=%22ferrous+iodide%22+anemia&source=bl&ots=ZGyFhUiJZ4&sig=IZOhRVaGmlwX7GcqgoE6rnCsCa4&hl=ru&sa=X&ved=0ahUKEwjYu7PCyYHUAhWiQpoKHR6cCfcQ6AEIUjAJ#v=onepage&q=%22ferrous%20iodide%22&f=false

There is no information about biological and pharmacological application of Iron(II) fluoride (also known as ferrous fluoride). It is known, that this substance is used to catalyze some organic reactions.

Originator

Approval Year

Conditions

Condition	Modality	Highest Phase	Product
Unknown 2596
Anemia 70 Sources: http://www.medicatione.com/?c=ing&s=ferrous%20aspartate	Palliative	Not Provided 511	Unknown Approved Use Unknown
Unknown 2596
Hypochromic anemia 37 Sources: https://www.ncbi.nlm.nih.gov/pubmed/16694502	Palliative	Not Provided 511	Unknown Approved Use Unknown
Unknown 2596
Unknown 2596
Unknown 2596
Iron deficiency 41 Sources: http://www.minapharm.com/Public/ProductDetails.aspx?ProductCode=FERRO_SANO&langParam=en	Primary	Approved 8583	Ferro Sanol Duodenal Approved Use Ferro Sanol is an iron substitute in case of latent or manifest iron deficiency with and without development of anaemia.
Radioactive cesium and/or radioactive or non-radioactive thallium internal contamination 37 Sources: https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/021626lbl.pdf	Curative	Approved 8583	RADIOGARDASE Approved Use Insoluble Prussian blue is indicated for treatment of patients with known or suspected internal contamination with radioactive cesium and/or radioactive or non-radioactive thallium to increase their rates of elimination. Launch Date 2003
Unknown 2596

PubMed

Title	Date	PubMed
FERROUS IODIDE AS A SUBSTITUTE FOR VITAMIN A IN RATS.	1932 Jul 1	17815234
[FERROUS ASPARTATE IN THERAPY].	1964 Jan 1	14116934
Endothelial dysfunction and inflammation induced by iron oxide nanoparticle exposure: Risk factors for early atherosclerosis.	2011 Jun 10	21439359
Reactivity enhancement of iron sulfide nanoparticles stabilized by sodium alginate: Taking Cr (VI) removal as an example.	2017 Jul 5	28371713
Continuous sulfidogenic wastewater treatment with iron sulfide sludge oxidation and recycle.	2017 May 1	28249212

Patents

Sample Use Guides

In Vivo Use Guide

Adults should usually take one capsule a day. In cases of pronounced iron deficiency, adults can be given a dosage 2 to 3 times higher at the beginning of therapy. A daily dose of more than 5 mg Fe2+/kg body weight should in-well founded exceptional cases not be exceeded.

Route of Administration: Oral

In Vitro Use Guide

Unknown

Substance Class	Chemical Created by `admin` on `Mon Mar 31 18:05:35 GMT 2025` Edited by `admin` on `Mon Mar 31 18:05:35 GMT 2025`
Record UNII	TLE294X33A
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

FERRIC FERROCYANIDE

Official Name

English

PRUSSIAN BLUE INSOLUBLE

Preferred Name

English

IRON(III) FERROCYANIDE

Common Name

English

RADIOGARDASE

Common Name

English

IRON(3+) FERROCYANIDE

Common Name

English

FERRIC HEXACYANOFERRATE

Common Name

English

FERRIC HEXACYANOFERRATE(II)

Common Name

English

FERRUM CYANATUM

Common Name

English

Ferric ferrocyanide [WHO-DD]

Common Name

English

PRUSSIAN BLUE

Common Name

English

PRUSSIAN BLUE [MI]

Common Name

English

INSOLUBLE PRUSSIAN BLUE

Common Name

English

FERRATE(4-), HEXAKIS(CYANO-.KAPPA.C)-, IRON(3+) (3:4) (OC-6-11)-

Common Name

English

FERRIC FERROCYANIDE [HSDB]

Common Name

English

FERRIC HEXACYANOFERRATE(II) [ORANGE BOOK]

Common Name

English

NSC-8665

Code

English

PRUSSIAN BLUE [MART.]

Common Name

English

FERRATE(4-), HEXACYANO-, IRON(3+) (3:4)

Common Name

English

PRUSSIAN BLUE INSOLUBLE [USAN]

Common Name

English

PRUSSIAN BLUE [VANDF]

Common Name

English

FERRUM CYANATUM [HPUS]

Common Name

English

ANTIDOTUM-THALLII-HEYL

Brand Name

English

FERRATE(4-), HEXAKIS(CYANO-C)-, IRON(3+) (3:4)

Common Name

English

Classification Tree Code System Code

FDA ORPHAN DRUG

169203